Radiopharm Theranostics Limited American Depositary Shares (RADX) — Defensive Interval Ratio
Radiopharm Theranostics Limited American Depositary Shares (RADX) has a Defensive Interval Ratio of 174 days as of December 2024. Defensive assets of $6.25 Million (cash $-, short-term investments $-, receivables $6.25 Million) cover 174 days of daily cash needs of $36.02K/day. See Radiopharm Theranostics Limited American net assets for net asset value and shareholders' equity analysis.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Radiopharm Theranostics Limited American Depositary Shares Defensive Interval Ratio (2022–2025)
This chart shows how Radiopharm Theranostics Limited American Depositary Shares's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2024, the ratio stands at 174 days, meaning defensive assets of $6.25 Million can fund 174 days of operations without new revenue. Explore how efficiently does Radiopharm Theranostics Limited American generate cash to assess how effectively this company generates cash.
Annual Defensive Interval Ratio for Radiopharm Theranostics Limited American Depositary Shares (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Radiopharm Theranostics Limited American Depositary Shares from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see RADX stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 254 days | $10.40 Million | $40.91K/day | $- | $- | ▲ +234 days |
| 2024 | 21 days | $987.41K | $48.15K/day | $- | $- | ▼ -103 days |
| 2023 | 123 days | $4.47 Million | $36.24K/day | $- | $- | ▲ +121 days |
| 2022 | 3 days | $56.48K | $21.59K/day | $- | $- | — |